young carer and elderly woman | Care Home Management

Dementia care feels the pinch of COVID-19

Antipsychotic medicine prescribing, and dementia diagnosis and care planning have paid the price of COVID-19, new statistics from Public Health England reveal.

PHE’s dementia profile update for the year to March 2021 shows the effect of COVID-19 on dementia care. The main research findings are as follows:

  • Since April 2020, there has been a consistent pattern of lower diagnosed prevalence rates for dementia in over 65-year-olds compared to before the pandemic
  • Since January 2020, there has been a consistent pattern of lower proportions of dementia patients receiving a care plan or review compared to before the pandemic, with the gap widening as the year progressed
  • The variation across CCGs in England of the proportion of patients receiving a care plan or review has increased significantly in December 2020 compared to before the pandemic
  • since March 2020, there has been a consistent pattern of higher antipsychotic prescribing rates for dementia patients compared to before the pandemic

Specifically, the research finds that diagnosis of dementia has decreased 5.4 percentage points compared to December 2019 to 62.4 per cent. This is below the Government’s own 2020 dementia targets for two-thirds of people with dementia and Alzheimer’s disease to have a formal diagnosis for their condition. Furthermore, since April 2020, there has been a consistent pattern of lower diagnosis rates when comparing the same months for each reporting year. April 2020 corresponds with the peak of the first wave of the coronavirus pandemic.

In terms of care planning, the data shows that care planning or care plan review for people diagnosed with dementia fell to in 46.8 per cent in December 2020, compared to 2019.

The proportion of patients with dementia and Alzheimer’s disease in England who were prescribed antipsychotic medication in the preceding six weeks had increased to 10.1 per cent in December 2020, up from 9.4 per cent the previous year.

Since March 2020, there has been a consistent pattern of significantly higher prescribing rates.

Facebooktwitterredditpinterestlinkedinmail
[pro_ad_display_adzone id=489]

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Subscribe to our newsletter
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Cookie Settings
Decline All
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Cookie Settings
Decline All
Accept All Cookies
Cookie Settings
STAY UPDATED!
Thank you for visiting CHMonline.co.uk, the website for the leading magazine for care home managers, operators and directors. If you would like to receive the digital edition and/or the editor's regular newsletters via email please subscribe here.
Are you a care home staff member or operator?
Terms: Care Home Management (S&A Publishing) may use the information you provide on this form to get in touch with you with relevant industry news and promotions. You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us. We will treat your information with respect. For more information please view our privacy policy.
By submitting this form you agree to the terms.
SUBSCRIBE